Clinical trial

Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples

NCT04011228

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Blood sampling Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Saliva and blood samples Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Magnet Resonance Spectroscopy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2016-02-29

PhaseN/A

Conditions

Prediabetic Stateunresolved

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Ectopic Lipidsunresolved

Epigenetics Based Modificationsunresolved

Interventions

Blood samplingDIAGNOSTIC_TEST

Saliva and blood samplesDIAGNOSTIC_TEST

Magnet Resonance SpectroscopyDIAGNOSTIC_TEST

Sponsors & collaborators

Medical University of Viennalead sponsor

Mapped research locations

ViennaAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04011228 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.